Torrey Spine Inc

TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Headquartered in San Diego, Calif., TearLab Corporation's common shares trade on the NASDAQ.

TearLab, now known as Trukera Medical, is a San Diego-based company that offers an objective and quantitative point-of-care diagnostic test called the TearLab Osmolarity System. This system measures the osmolarity of human tears, providing precise and predictive information to aid in the diagnosis of dry eye disease in patients suspected of having the condition. The TearLab Osmolarity Test Card, used in conjunction with the TearLab Osmolarity System, offers a quick and simple method for determining tear osmolarity. By collecting tear fluid directly from the eyelid margin, the test provides an indirect assessment of osmolarity, allowing healthcare professionals to make informed clinical evaluations and provide appropriate treatment for patients with dry eye disease.Generated from the website

Next Orthosurgical Inc, located in Vista, CA, is a leading provider of orthopedic surgical products. With a dedicated team of professionals, they offer a range of innovative solutions to meet the needs of their clients. Specializing in orthopedic implants and instruments, Next Orthosurgical Inc is committed to delivering high-quality products and exceptional customer service. Their focus on precision and reliability makes them a trusted partner in the orthopedic industry. Generated from the website